AI-Rad Companion Prostate MR

by Siemens Medical Solutions USA  · Based in United States → — AI-powered assistance for prostate MR image interpretation and biopsy support.
Radiology Urology

Contact for pricing
Regulatory Status Disclosed

Overview

AI-Rad Companion Prostate MR is a post-processing image analysis software developed by Siemens Medical Solutions USA. It is designed to assist radiologists in the preparation and evaluation of MR prostate images, particularly for the planning of targeted MR-Ultrasound fusion biopsies. The software leverages artificial intelligence algorithms and a cloud infrastructure to provide quantitative and qualitative information based on prostate MR DICOM images.

The tool aims to streamline the workflow for radiologists by automating routine and time-consuming tasks, such as prostate gland segmentation and volume estimation. This automation can reduce the time spent on manual contouring, allowing radiologists to focus on more critical aspects of image interpretation. It also facilitates improved communication between radiologists and urologists by enabling the export of annotated images, including prostate volume and manually marked lesions, in DICOM and RTSTRUCT formats for use in biopsy guidance.

AI-Rad Companion Prostate MR integrates seamlessly into the clinical image interpretation workflow, supporting evidence-based decisions and potentially enhancing diagnostic precision. It is deployed via the teamplay digital health platform, which also allows for regular updates and integration of new offerings.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated prostate segmentation and volume estimation
  • Manual adjustment of prostate segmentation
  • Manual determination of lesion location and size
  • Calculation of PSA density (if PSA value is known)
  • Export of segmentations and targets in DICOM and RTSTRUCT formats
  • Integration into existing image interpretation workflow (PACS)
  • Support for MR-Ultrasound fusion biopsies
  • Automated measurements and DICOM structured reports
  • Cloud-based deployment via teamplay digital health platform

Use Cases

  • Prostate biopsy planning support
  • Assisting radiologists in interpreting multiparametric Prostate MRI
  • Improving diagnostic workflow efficiency in radiology
  • Facilitating targeted MR-US fusion biopsies
  • Standardizing communication of findings between radiologists and urologists
  • Reducing manual contouring time for prostate glands

What Physicians Need to Know

Key Capabilities
Automatically segments the prostate and estimates its volume, significantly reducing manual contouring time. It allows radiologists to manually mark and characterize lesions, and calculates PSA density if the PSA value is provided. The system exports results in DICOM and DICOM RT-STRUCT formats for reading, archiving, and import by ultrasound systems for targeted MR-US fusion biopsies. In some versions (VA40, not VA30 in the US), it also offers lesion candidate localization and classification with pre-populated PI-RADS reports.
Clinical Utility
Aids in targeted prostate biopsies by providing precise anatomical and lesion information to urologists, potentially improving the detection of significant prostate carcinomas. It helps radiologists manage workload by automating routine segmentation tasks and can improve lesion assessment accuracy, particularly for less-experienced radiologists, while potentially reducing reading times and lesion grading variability.
Integration Options
Seamlessly integrates into existing clinical workflows and is DICOM compliant. It can be used with MRI scanners from Siemens Healthineers and other manufacturers. The software is available on the teamplay cloud-based digital health platform, and results can be transferred to PACS and reporting templates, or exported as RTSTRUCT objects for fusion with ultrasound images during biopsy.
Compliance Status
FDA 510(k) cleared (specifically the Biopsy Support version). It is DICOM compliant, and its cloud-based infrastructure (teamplay) adheres to HIPAA and EU GDPR regulations. Siemens Healthineers also follows FDA guidance on cybersecurity for medical devices.
Pricing Model
Offered under a subscription-based Software as a Service (SaaS) model. A trial license, typically for 90 days, is often available for evaluation.
User Experience
Designed to be an intelligent companion that integrates smoothly into the radiologist's workflow. It provides a transparent and concise presentation of information, offering quick access to decision-support data without requiring extensive prior adjustments, aiming to reduce the burden of repetitive tasks.
Implementation Complexity
Described as seamlessly integrated into existing clinical workflows. Installation and use of the teamplay digital health platform are prerequisites for its operation, suggesting a cloud-based deployment with a manageable setup.
Evidence Base
A European Radiology study indicated that the solution can improve radiologists' lesion assessment accuracy (significantly for less-experienced radiologists and modestly for experienced ones), reduce reading times, and decrease lesion grading variability. Siemens Healthineers actively supports its AI portfolio through academic research. Clinical studies are also underway to investigate its impact on prostate cancer workflow.
Physician Tip

Leverage AI-Rad Companion Prostate MR to streamline prostate segmentation and volume estimation, freeing up time for more complex diagnostic tasks. Pay close attention to the AI-generated contours and lesion suggestions, using them as a powerful second opinion, but always perform manual review and adjustment as needed. The ability to export annotated images as RTSTRUCT is crucial for facilitating precise MR-US fusion biopsies, enhancing interdisciplinary communication with urologists. For less experienced radiologists, this tool can significantly boost diagnostic confidence and accuracy.

The AI-Rad Companion Prostate MR is highly adaptable, being DICOM compliant and compatible with MRI scanners from various manufacturers. Its integration into the teamplay cloud-based digital health platform ensures accessibility and seamless updates. The capability to export results directly to PACS and, critically, as RTSTRUCT files for ultrasound systems, makes it a valuable asset for a connected prostate cancer diagnostic and biopsy workflow.

Details

Category Oncology AI, Radiology & Imaging AI
Pricing Contact for pricing — Subscription-based software as a service (SaaS) model.
DeploymentHybrid (Cloud-based via teamplay digital health platform with on-premise access through syngo.via).
Compliance
BAA AvailableUnknown AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status 1 AI-estimated

Cleared by the FDA under K193283 on July 30, 2020. It is a post-processing image analysis software that assists clinicians in viewing, manipulating, analyzing, and evaluating MR prostate images for US guided MR-US fusion biopsy support.

Integrations
EHR Not specified
Specialties Radiology, Urology

What the Web Says

Siemens Healthineers' AI-Rad Companion Prostate MR is a cloud-based, AI-powered image processing software designed to assist radiologists in analyzing prostate MRI images for biopsy support. It aims to improve diagnostic accuracy, particularly for less-experienced radiologists, and streamline workflows by automating routine tasks like prostate segmentation. The software has received FDA clearance and is being evaluated in clinical trials.

Overall: Positive

Strengths

  • Automates prostate gland segmentation, saving time compared to manual methods.
  • Improves lesion assessment accuracy, especially for less-experienced radiologists.
  • Reduces reading times for prostate MRI exams.
  • Decreases lesion grading variability among radiologists.
  • Facilitates targeted prostate biopsies by enabling radiologists to mark suspect areas for urologists.
  • Vendor-agnostic, meaning it can be used with MRI scanners from Siemens Healthineers and other manufacturers.

Limitations

  • Current literature on many FDA-cleared AI tools, including this one, remains limited, requiring further research to evaluate usability in clinical settings.
  • While it significantly benefits less-experienced radiologists, the performance improvement for experienced radiologists is modest.
  • Requires a cloud-based infrastructure, which might be a consideration for some healthcare IT environments.
  • Although it aids in diagnosis, it cannot provide a histological diagnosis, which still requires a biopsy.

Based on reviews from: accessdata.fda.gov, The Imaging Wire, SelectScience, Cleveland Clinic Consult QD, Cassling, BioWorld, Applied Radiology, DOKUMEN.PUB, PMC (PubMed Central)

Last updated: 2026-07-20

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate AI-Rad Companion Prostate MR

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for AI-Rad Companion Prostate MR.

View all on YouTube

Frequently Asked Questions

AI-Rad Companion Prostate MR seamlessly integrates into existing clinical workflows, being DICOM compliant and usable with MRI scanners from various manufacturers. It automates prostate gland segmentation and volume estimation, and in some versions, assists with lesion detection and pre-populating PI-RADS reports, significantly reducing manual contouring time.
AI-Rad Companion Prostate MR has received FDA clearance for biopsy support and is CE-marked (MDD - IIb) in Europe. It ensures patient data privacy and security by being compliant with HIPAA and EU GDPR, utilizing a certified, secure cloud-based teamplay infrastructure that implements principles of data minimization.
AI-Rad Companion Prostate MR differentiates itself by automating time-consuming tasks like prostate segmentation and volume calculation, which traditionally require significant manual effort. While other AI solutions exist, this system aims to enhance diagnostic precision, reduce inter-reader variability, and facilitate targeted MR-US fusion biopsies by providing structured data.
AI-Rad Companion Prostate MR is typically offered under a subscription-based Software as a Service (SaaS) model, with pricing often tied to the number of analyses performed. A 90-day trial license is usually available for evaluation before committing to a purchase.
Known limitations include potential variations in functionality across regions, such as the VA30 version in the US not offering automated lesion detection or pre-populated PI-RADS reports. Physician oversight remains crucial, as the radiologist is still responsible for marking suspect areas and making final diagnostic decisions.
Multiple peer-reviewed studies and clinical trials support the efficacy of AI-Rad Companion Prostate MR, demonstrating its ability to assist in detecting clinically significant prostate cancer, improve PI-RADS scoring, and reduce inter-reader variability. Research indicates that AI systems can achieve diagnostic performance comparable to or even superior to radiologists in certain aspects of prostate MRI interpretation.

Related Tools

Surgical Reality Viewer
Surgical Reality
Oncology AI
Surgical Reality offers CE- and FDA-certified AI-powered 3D medical imaging and surgical planning software that transforms CT scans into patient-specific 3D models for thoracic surgery, enhancing precision in complex lung procedures.
Cancer Copilot
Color Health
Oncology AI
Color Health's Cancer Copilot, built with OpenAI, helps oncologists and clinicians identify and order workup needs for recently diagnosed patients, aiming to speed up time to cancer treatment. This AI tool is designed to expand cancer expertise, speed decisions, and improve care, reducing a two-hour clinical task to 10 minutes with over 95% validated accuracy.
Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
Synapse Lung Nodule AI
Fujifilm Corporation
Oncology AI
Fujifilm's Synapse Lung Nodule AI is an AI software algorithm for detecting pulmonary nodules on CT imaging, aiming to support early detection and treatment of lung cancer.
RadOncAI
Informai (for RadOncAI product) / Global Network for AI in Radiation Oncology (for RadoncAI.net)
Oncology AI
RadOncAI is an AI solution by Informai designed to optimize and enhance radiation oncology workflows, improving efficiency and accuracy in treatment planning and delivery.
FAITH project (Fatigue Therapy – AI-supported Diagnosis and Therapy of Tumour-associated Fatigue Syndrome)
Fimo Health GmbH (Consortium Leader)
Mental & Behavioral Health AI
The FAITH project is developing an AI-based solution for the diagnosis and therapy of tumor-associated fatigue syndrome in cancer patients. It uses wearable sensors, a smartphone app, and artificial intelligence to provide individualized therapy recommendations and monitor mental health.

See all Oncology AI tools →

More from Siemens Medical Solutions USA

ACUSON Sequoia Diagnostic Ultrasound System
Siemens Medical Solutions USA
Radiology & Imaging AI
The ACUSON Sequoia Diagnostic Ultrasound System by Siemens Healthineers is a premium platform featuring BioAcoustic imaging, InFocus technology, and AI-powered tools to deliver consistent, high-resolution ultrasound imaging across diverse patient types and clinical applications.
AI Rad Companion (Engine)
Siemens Medical Solutions USA
Radiology & Imaging AI
Siemens AI-Rad Companion (Engine) is an FDA-cleared, AI-powered, cloud-based platform that streamlines radiology workflows and enhances diagnostic precision through automated image post-processing and structured reporting across multiple modalities.
AI-Rad Companion (Musculoskeletal)
Siemens Medical Solutions USA
Radiology & Imaging AI
AI-Rad Companion (Musculoskeletal) by Siemens Medical Solutions USA is an FDA-cleared AI-powered image processing software for quantitative and qualitative analysis of musculoskeletal conditions from CT DICOM images, supporting radiologists and physicians in diagnostic evaluation.
AI-Rad Companion Engine
Siemens Medical Solutions USA
Radiology & Imaging AI
The AI-Rad Companion Engine is an AI-powered, cloud-based platform by Siemens Medical Solutions USA that automates post-processing and enhances diagnostic precision in medical image interpretation across multiple modalities.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-19 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.